SomnoMed Limited

Equities

SOM

AU000000SOM1

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 11:17:03 05/06/2024 am IST			5-day change	1st Jan Change
0.26 ^AUD	-3.70%		-5.45%	-48.00%

13/05	SomnoMed Pays Loan from Epsilon Direct Lending; Shares Rise 5%	MT
05/05	SomnoMed Completes AU$16.8 Million Retail Entitlement Offer	MT

Somnomed Limited Announces Executive Changes

July 19, 2016 at 05:03 am IST

The board of SomnoMed Limited announced the appointment of the Derek Smith as new global CEO from September 1, 2016. Dr. Peter Neustadt, the current global CEO and Executive Chairman of SomnoMed Limited will return to his previous role of non- executive Chairman after transferring global executive responsibilities during the month of September.

Latest news about SomnoMed Limited

SomnoMed Pays Loan from Epsilon Direct Lending; Shares Rise 5%	13/05	MT
SomnoMed Completes AU$16.8 Million Retail Entitlement Offer	06/05	MT
Somnomed Raises AU$5.8 Million in Institutional Entitlement Offer; AU$16.8 Million Retail Component to Launch April 16	10/04	MT
SomnoMed Lowers Earnings, Revenue Guidance for Fiscal 2024; to Launch AU$22.6 Million Entitlement Offer	09/04	MT
Somnomed Requests Voluntary Share Suspension Continuation	05/04	MT
Wilsons Downgrades Somnomed to Marketweight From Overweight; Price Target is AU$0.45	14/03	MT
SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02	CI
SomnoMed Appoints Co-CEOs	22/02	MT
SomnoMed Grows Fiscal Q1 Revenue	30/23/30	MT
SomnoMed Limited Announces Resignation of Hilton Brett as Non-Executive Director	12/23/12	CI
Transcript : SomnoMed Limited, 2023 Earnings Call, Aug 31, 2023	31/23/31
SomnoMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/23/31	CI
Somnomed Limited Announces Executive Changes	05/23/05	CI
SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/23/22	CI
SomnoMed Limited Reaffirms Earnings Guidance for the Year 2023	29/22/29	CI
Transcript : SomnoMed Limited, 2022 Earnings Call, Aug 23, 2022	23/22/23
Somnomed Fiscal Q4 Revenue Rises 32%	26/22/26	MT
Transcript : SomnoMed Limited, H1 2022 Earnings Call, Feb 22, 2022	22/22/22
SomnoMed Introduces Rest Assure	22/22/22	CI
SomnoMed Limited Provides Earnings Guidance for the Second Half of Fiscal Year 2022 and Reaffirms Earnings Guidance for the Fiscal Year 2022	22/22/22	CI
SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22/22/22	CI
SomnoMed Develops Technology-Enabled Oral Appliance	31/22/31	MT
SomnoMed Limited Announces World First Technology Enabled Oral Appliance	31/22/31	CI
Transcript : SomnoMed Limited - Shareholder/Analyst Call	25/21/25
SomnoMed : Fiscal Q1 Revenue Rises 14%; Shares Climb 6%	26/21/26	MT

Chart SomnoMed Limited

Duration

Period

More charts

Company Profile

SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Companyâs segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.

Sector

Medical Equipment, Supplies & Distribution

Calendar

27/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for SomnoMed Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.27 AUD

Average target price

0.23 AUD

Spread / Average Target

-14.81%

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SOMNOMED LIMITED	-48.00%	38.79M
ABBOTT LABORATORIES	-6.03%	180B
MEDTRONIC PLC	+1.08%	109B
BECTON, DICKINSON AND COMPANY	-2.19%	68.93B
DEXCOM, INC.	-5.98%	46.41B
CENCORA, INC.	+12.31%	45.43B
HOYA CORPORATION	+7.38%	43.26B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.98%	30.05B
TERUMO CORPORATION	+16.10%	25.19B
WEST PHARMACEUTICAL SERVICES, INC.	-9.57%	23.19B

Other Medical Equipment, Supplies & Distribution